154 related articles for article (PubMed ID: 20444990)
1. Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor kappaB activation.
McCoy LE; Fahy AS; Chen RA; Smith GL
J Gen Virol; 2010 Sep; 91(Pt 9):2216-20. PubMed ID: 20444990
[TBL] [Abstract][Full Text] [Related]
2. Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
Benfield CT; Mansur DS; McCoy LE; Ferguson BJ; Bahar MW; Oldring AP; Grimes JM; Stuart DI; Graham SC; Smith GL
J Biol Chem; 2011 Jun; 286(23):20727-35. PubMed ID: 21474453
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of IkappaB kinase by vaccinia virus virulence factor B14.
Chen RA; Ryzhakov G; Cooray S; Randow F; Smith GL
PLoS Pathog; 2008 Feb; 4(2):e22. PubMed ID: 18266467
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
García-Arriaza J; Gómez CE; Sorzano CÓ; Esteban M
J Virol; 2014 Mar; 88(6):3392-410. PubMed ID: 24390336
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
J Virol; 2019 May; 93(10):. PubMed ID: 30814284
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence.
Ember SWJ; Ren H; Ferguson BJ; Smith GL
J Gen Virol; 2012 Oct; 93(Pt 10):2098-2108. PubMed ID: 22791606
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
Ryerson MR; Shisler JL
Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
[TBL] [Abstract][Full Text] [Related]
8. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
Shisler JL; Jin XL
J Virol; 2004 Apr; 78(7):3553-60. PubMed ID: 15016878
[TBL] [Abstract][Full Text] [Related]
9. The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation.
Martin S; Harris DT; Shisler J
J Virol; 2012 Sep; 86(18):9629-39. PubMed ID: 22740414
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor.
Chen RA; Jacobs N; Smith GL
J Gen Virol; 2006 Jun; 87(Pt 6):1451-1458. PubMed ID: 16690909
[TBL] [Abstract][Full Text] [Related]
11. Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.
Sumner RP; Ren H; Ferguson BJ; Smith GL
Vaccine; 2016 Sep; 34(40):4827-34. PubMed ID: 27544585
[TBL] [Abstract][Full Text] [Related]
12. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
13. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.
Clark RH; Kenyon JC; Bartlett NW; Tscharke DC; Smith GL
J Gen Virol; 2006 Jan; 87(Pt 1):29-38. PubMed ID: 16361415
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence.
Maluquer de Motes C; Cooray S; Ren H; Almeida GM; McGourty K; Bahar MW; Stuart DI; Grimes JM; Graham SC; Smith GL
PLoS Pathog; 2011 Dec; 7(12):e1002430. PubMed ID: 22194685
[TBL] [Abstract][Full Text] [Related]
15. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
[TBL] [Abstract][Full Text] [Related]
16. Leaky scanning translation generates a second A49 protein that contributes to vaccinia virus virulence.
Neidel S; Torres AA; Ren H; Smith GL
J Gen Virol; 2020 May; 101(5):533-541. PubMed ID: 32100702
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor.
Ren H; Ferguson BJ; Maluquer de Motes C; Sumner RP; Harman LE; Smith GL
Immunology; 2015 May; 145(1):34-49. PubMed ID: 25382035
[TBL] [Abstract][Full Text] [Related]
18. Early viral protein synthesis is necessary for NF-kappaB activation in modified vaccinia Ankara (MVA)-infected 293 T fibroblast cells.
Martin S; Shisler JL
Virology; 2009 Aug; 390(2):298-306. PubMed ID: 19539971
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence.
Ferguson BJ; Benfield CTO; Ren H; Lee VH; Frazer GL; Strnadova P; Sumner RP; Smith GL
J Gen Virol; 2013 Sep; 94(Pt 9):2070-2081. PubMed ID: 23761407
[TBL] [Abstract][Full Text] [Related]
20. Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection.
Hinthong O; Jin XL; Shisler JL
Virology; 2008 Apr; 373(2):248-62. PubMed ID: 18190944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
